Valproate-induced burning mouth syndrome in a male with fibromyalgia and bipolar spectrum disorder
Burning mouth syndrome is a chronic painful condition characterized by a subjective intraoral pain and burning sensations in the absence of an identifiable medical, dental, or psychiatric cause. Although the underlying etiology is currently unclear, an idiopathic (or primary) form and a secondary form to other conditions are formally recognized. However, as several authors have suggested, it might be of clinical utility to consider the existence of a third clinical entity, namely Drug-Induced Burning mouth syndrome, for its therapeutic implications. The latter has been reported with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, antiretrovirals, anticoagulants, chemotherapy, and drugs commonly used in the treatment of neuropsychiatric disorders such as antidepressants, benzodiazepines, and antipsychotics. Regarding anticonvulsants a literature search found a previous case of Topiramate-Induced Burning mouth syndrome but no previous report of valproate-induced Burning mouth syndrome. Our case is, to date, the first case in the literature of Burning mouth syndrome onset following the administration of valproate to a patient suffering from fibromyalgia and bipolar spectrum disorder. Symptoms resolved completely when the drug was stopped, and the association between symptoms and drug was replicated after drug re-administration.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Archive of clinical cases - 10(2023), 3 vom: 01., Seite 125-127 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Raia, Accursio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bipolar disorder |
|---|
| Anmerkungen: |
Date Revised 23.09.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.22551/2023.40.1003.10257 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362331944 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362331944 | ||
| 003 | DE-627 | ||
| 005 | 20231226091021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.22551/2023.40.1003.10257 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1207.xml |
| 035 | |a (DE-627)NLM362331944 | ||
| 035 | |a (NLM)37736595 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Raia, Accursio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Valproate-induced burning mouth syndrome in a male with fibromyalgia and bipolar spectrum disorder |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.09.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Burning mouth syndrome is a chronic painful condition characterized by a subjective intraoral pain and burning sensations in the absence of an identifiable medical, dental, or psychiatric cause. Although the underlying etiology is currently unclear, an idiopathic (or primary) form and a secondary form to other conditions are formally recognized. However, as several authors have suggested, it might be of clinical utility to consider the existence of a third clinical entity, namely Drug-Induced Burning mouth syndrome, for its therapeutic implications. The latter has been reported with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, antiretrovirals, anticoagulants, chemotherapy, and drugs commonly used in the treatment of neuropsychiatric disorders such as antidepressants, benzodiazepines, and antipsychotics. Regarding anticonvulsants a literature search found a previous case of Topiramate-Induced Burning mouth syndrome but no previous report of valproate-induced Burning mouth syndrome. Our case is, to date, the first case in the literature of Burning mouth syndrome onset following the administration of valproate to a patient suffering from fibromyalgia and bipolar spectrum disorder. Symptoms resolved completely when the drug was stopped, and the association between symptoms and drug was replicated after drug re-administration | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Burning mouth syndrome | |
| 650 | 4 | |a Neuropathic pain | |
| 650 | 4 | |a Stomatodynia | |
| 650 | 4 | |a Valproate | |
| 650 | 4 | |a bipolar disorder | |
| 650 | 4 | |a fibromyalgia | |
| 700 | 1 | |a Caruso, Valerio |e verfasserin |4 aut | |
| 700 | 1 | |a Montalbano, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Migli, Lavinia |e verfasserin |4 aut | |
| 700 | 1 | |a Raia, Calogero |e verfasserin |4 aut | |
| 700 | 1 | |a Pini, Stefano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archive of clinical cases |d 2019 |g 10(2023), 3 vom: 01., Seite 125-127 |w (DE-627)NLM332928764 |x 2360-6975 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:3 |g day:01 |g pages:125-127 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.22551/2023.40.1003.10257 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |e 3 |b 01 |h 125-127 | ||